Dentition defect
Conditions
Interventions
The postoperative oral dexamethasone group:Postoperative oral dexamethasone
The intraoperative submucosal injection dexamethasone group:Intraoperative submucosal injection of dexamethasone
Sponsors
Affiliated Stomatological Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged 18~65 with dentition defects, and those who have no continuous tooth loss in the same quadrant in the mouth, and there is no special requirement for gender; (2) The patient has good compliance, is informed and agrees to participate in this study; (3) No systemic diseases or bone metabolism diseases, no other oral and facial diseases such as chronic minor sinusitis, history of parotid gland surgery, etc.; (4) tolerate implant surgery; (5) Denial of dexamethasone allergy.
Exclusion criteria
Exclusion criteria: (1) Patients with systemic diseases, such as diabetes mellitus or osteoporosis or inflammatory bowel disease; (2) Patients with active infection or inflammation in the implant area, or obvious apical inflammation of adjacent teeth; (3) History of head and neck radiotherapy; (4) Patients with insufficient available bone mass and need to undergo bone augmentation operation; (5) Those who have taken glucocorticoids in the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain level;Swelling score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of surgery;Number of implants; | — |
Countries
China
Contacts
Public ContactHe Feng
Affiliated Stomatological Hospital of Nanjing Medical University
Outcome results
None listed